Published in Arch Neurol on March 01, 2012
Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Ann Neurol (2013) 1.14
Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. Am J Neurodegener Dis (2013) 1.08
Recent developments in biomarkers in Parkinson disease. Curr Opin Neurol (2013) 1.00
Statins, plasma cholesterol, and risk of Parkinson's disease: a prospective study. Mov Disord (2015) 0.93
Blood-based biomarkers for Parkinson's disease. Parkinsonism Relat Disord (2014) 0.88
Statin use and risk of Parkinson's disease: a meta-analysis of observational studies. J Neurol (2012) 0.88
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Mov Disord (2014) 0.84
Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's disease. J Pharmacol Exp Ther (2013) 0.83
Vascular risk factors and clinical progression in spinocerebellar ataxias. Tremor Other Hyperkinet Mov (N Y) (2015) 0.80
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis. PLoS One (2016) 0.80
Enhancing case ascertainment of Parkinson's disease using Medicare claims data in a population-based cohort: the Cardiovascular Health Study. Pharmacoepidemiol Drug Saf (2013) 0.79
Parkinson's disease between internal medicine and neurology. J Neural Transm (Vienna) (2015) 0.77
Integrated molecular landscape of Parkinson's disease. NPJ Parkinsons Dis (2017) 0.76
Age, statin use, and the risk for incident Parkinson disease. Arch Neurol (2012) 0.75
Statin adherence and the risk of Parkinson's disease: A population-based cohort study. PLoS One (2017) 0.75
Parkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options. P T (2015) 0.75
Statin Use and Its Association with Essential Tremor and Parkinson's Disease. Neuroepidemiology (2016) 0.75
Do physical exercise and reading reduce the risk of Parkinson's disease? a cross-sectional study on factors associated with Parkinson's disease in elderly Chinese veterans. Neuropsychiatr Dis Treat (2015) 0.75
Reply to letter: Plasma fasting cholesterol profiles and age at onset in Parkinson's disease. Mov Disord (2015) 0.75
Aging of perennial cells and organ parts according to the programmed aging paradigm. Age (Dordr) (2016) 0.75
Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging (2002) 22.40
Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90
Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ (2010) 5.19
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol (2002) 4.60
Trends in statin use and low-density lipoprotein cholesterol levels among US adults: impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmacother (2008) 3.20
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women. Ann Neurol (2001) 3.09
Plasma urate and risk of Parkinson's disease. Am J Epidemiol (2007) 3.06
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol (2009) 2.78
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Family history of melanoma and Parkinson disease risk. Neurology (2009) 2.25
Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease. Mov Disord (2007) 2.24
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio. Br J Clin Pharmacol (1996) 1.24
Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med (1997) 1.17
Statin use and the risk of Parkinson disease. Neurology (2008) 1.10
Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci (2010) 1.05
Modulation of inflammatory mediators and PPARgamma and NFkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res (2002) 1.05
Lovastatin ameliorates alpha-synuclein accumulation and oxidation in transgenic mouse models of alpha-synucleinopathies. Exp Neurol (2009) 1.04
Statins: multiple neuroprotective mechanisms in neurodegenerative diseases. Exp Neurol (2010) 1.04
Use of cholesterol-lowering medications in the United States from 1991 to 1997. Am J Med (2000) 1.03
Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK. Drug Saf (2008) 1.02
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis (2002) 1.01
Statin use and Parkinson's disease in Denmark. Mov Disord (2010) 0.93
Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease. Mov Disord (2007) 0.92
Statin use and the risk of Parkinson disease: a nested case control study. J Clin Neurosci (2008) 0.92
The effect of Simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolaemia. Clin Chim Acta (1997) 0.86
Statins and the risk of Parkinson disease: an update on the controversy. Expert Opin Drug Saf (2009) 0.84
Total cholesterol and the risk of Parkinson's disease: a review for some new findings. Parkinsons Dis (2009) 0.82
Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids (2010) 0.81
Parkinsonism unmasked by lovastatin. Ann Neurol (1995) 0.79
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA (2006) 7.09
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Genome-wide association study of circulating vitamin D levels. Hum Mol Genet (2010) 4.07
Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med (2010) 3.66
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann Neurol (2005) 3.58
Coffee, caffeine, and risk of depression among women. Arch Intern Med (2011) 3.05
Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A (2007) 3.03
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol (2009) 2.95
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol (2003) 2.90
Pesticide exposure and risk for Parkinson's disease. Ann Neurol (2006) 2.89
Serum urate as a predictor of clinical and radiographic progression in Parkinson disease. Arch Neurol (2008) 2.79
Genetic determinants of hair color and Parkinson's disease risk. Ann Neurol (2009) 2.78
Use of ibuprofen and risk of Parkinson disease. Neurology (2011) 2.70
Retracted Multiple sclerosis and Epstein-Barr virus. JAMA (2003) 2.68
Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med (2004) 2.60
Smoking is a risk factor for multiple sclerosis. Neurology (2003) 2.55
Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol (2007) 2.53
Physical activity and risk of coronary heart disease in India. Int J Epidemiol (2004) 2.48
Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology (2013) 2.47
Depression and incident stroke in women. Stroke (2011) 2.47
Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol (2009) 2.46
Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci (2005) 2.34
Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol (2006) 2.33
Alcohol consumption and risk for coronary heart disease among men with hypertension. Ann Intern Med (2007) 2.30
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA (2005) 2.23
Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J Clin Invest (2003) 2.22
Periodontal disease, tooth loss, and incidence of ischemic stroke. Stroke (2003) 2.19
Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease. Mov Disord (2012) 2.18
Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation (2005) 2.12
Fish consumption and risk of stroke in men. JAMA (2002) 2.08
Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension (2007) 2.05
Vitamin C intake and serum uric acid concentration in men. J Rheumatol (2008) 2.05
Diet and risk of ischemic heart disease in India. Am J Clin Nutr (2004) 2.02
Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol (2006) 2.00
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology (2007) 1.97
Dietary fat intake and risk of stroke in male US healthcare professionals: 14 year prospective cohort study. BMJ (2003) 1.94
Adipose tissue alpha-linolenic acid and nonfatal acute myocardial infarction in Costa Rica. Circulation (2003) 1.90
Body size and risk of MS in two cohorts of US women. Neurology (2009) 1.89
Smoking and Parkinson's disease: using parental smoking as a proxy to explore causality. Am J Epidemiol (2009) 1.87
Obesity, diabetes, and risk of Parkinson's disease. Mov Disord (2011) 1.85
Gestational vitamin D and the risk of multiple sclerosis in offspring. Ann Neurol (2011) 1.85
Oral health and peripheral arterial disease. Circulation (2003) 1.83
Prenatal and perinatal factors and risk of multiple sclerosis. Epidemiology (2009) 1.80
Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br J Pharmacol (2006) 1.79
Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol (2007) 1.74
Diet, urate, and Parkinson's disease risk in men. Am J Epidemiol (2008) 1.69
Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration. Exp Neurol (2010) 1.66
Obesity and restless legs syndrome in men and women. Neurology (2009) 1.61
Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology (2003) 1.57
Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr (2007) 1.57
Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin. Am J Pathol (2002) 1.53
Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry (2011) 1.53
Cigarette smoking and the progression of multiple sclerosis. Brain (2005) 1.52
Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors. Am J Pathol (2002) 1.50
Perinatal air pollutant exposures and autism spectrum disorder in the children of Nurses' Health Study II participants. Environ Health Perspect (2013) 1.49
Prospective study of restless legs syndrome and risk of erectile dysfunction. Am J Epidemiol (2013) 1.47
Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol (2004) 1.46
Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol (2002) 1.46
Recreational physical activity and risk of Parkinson's disease. Mov Disord (2008) 1.45
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann Neurol (2010) 1.45
Intakes of vitamin C and carotenoids and risk of amyotrophic lateral sclerosis: pooled results from 5 cohort studies. Ann Neurol (2013) 1.45
Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr (2004) 1.44
Weight loss in Parkinson's disease. Ann Neurol (2003) 1.43
Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord (2013) 1.42
Fruit and vegetable consumption and cognitive decline in aging women. Ann Neurol (2005) 1.38
Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk. Mov Disord (2012) 1.38
RLS in middle aged women and attention deficit/hyperactivity disorder in their offspring. Sleep Med (2011) 1.38
Individual carotenoid concentrations in adipose tissue and plasma as biomarkers of dietary intake. Am J Clin Nutr (2002) 1.37
Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr (2004) 1.35
Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener (2012) 1.34
Telomere length and risk of Parkinson's disease. Mov Disord (2008) 1.31
Relation between clinical depression risk and physical activity and time spent watching television in older women: a 10-year prospective follow-up study. Am J Epidemiol (2011) 1.31
Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol (2005) 1.27
Prospective study of phobic anxiety and risk of Parkinson's disease. Mov Disord (2003) 1.26
Interactions between metabotropic glutamate 5 and adenosine A2A receptors in normal and parkinsonian mice. J Neurosci (2005) 1.24
Consumption of dairy products and risk of Parkinson's disease. Am J Epidemiol (2007) 1.23
Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol (2011) 1.23
Sleep regulation in adenosine A2A receptor-deficient mice. Neurology (2003) 1.22
Alcohol and risk for ischemic stroke in men: the role of drinking patterns and usual beverage. Ann Intern Med (2005) 1.22
Tooth loss and dietary intake. J Am Dent Assoc (2003) 1.21
Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol (2003) 1.19
Dietary intake of n-3 and n-6 fatty acids and the risk of clinical depression in women: a 10-y prospective follow-up study. Am J Clin Nutr (2011) 1.19